Affordable Automation for Proteomics—Opentrons Introduces Flex Proteomics Workstation

New proteomics workstation on black background

A cost-effective solution for high-throughput MS sample prep

Opentrons Labworks, Inc. has unveiled the Opentrons Flex® Proteomics Workstation, a cutting-edge automated system for proteomics workflows designed to significantly reduce hands-on time and cost. Unlike traditional proteomics automation solutions that often exceed six figures, the Flex Proteomics Workstation offers advanced mass spectrometry (MS) sample preparation in a more budget-friendly price range.

Automating complex proteomics workflows

The new workstation streamlines critical proteomics processes, including:

  • Protein digestion (SP3)
  • Quantification and labeling
  • Purification steps

With integrated liquid handling, an on-deck plate reader, a heater-shaker, and a magnetic block, researchers can perform multiple sample preparation workflows on a single platform. Users can leverage Opentrons' verified protocols or customize their own for maximum flexibility.

Advancing biomarker research and drug discovery

According to Hanno Steen, PhD, Director of the Proteomics Center at Boston Children's Hospital, automation is key to overcoming bottlenecks in proteomics research. By eliminating repetitive manual tasks, the Flex Proteomics Workstation enhances consistency, reduces sample loss, and accelerates biomarker discovery.

With over 10,000 Opentrons robots installed worldwide, this new platform is poised to make high-throughput proteomics more accessible for academic labs, biotech startups, and pharmaceutical companies. The Flex Proteomics Workstation will be showcased at the upcoming US HUPO conference (February 24–25).

Key Features of the Opentrons Flex Proteomics Workstation:

  • Automates MS sample prep, reducing hands-on time
  • Affordable pricing in the mid-five-figure range
  • Compatible with verified protocols or custom workflows
  • Integrated liquid handling, plate reader, heater-shaker, and magnetic block
  • Supports biomarker research and drug development

This article has been sourced from a press release and may include content created or refined using AI tools and verified by our editorial team. For the full press release, visit: BusinessWire